Defense Secretary Pete Hegseth’s new initiative to test and treat troops for low testosterone has prompted a federal judge to question the differences between that kind of testosterone replacement ...

Chronic, low-grade inflammation in the body-a phenomenon known as "inflammaging" because it increases with age-has been ...

Chronic, low-grade inflammation in the body—a phenomenon known as "inflammaging" because it increases with age—has been ...

Scientists are getting closer to understanding the wasting and fatigue that often accompanies cancer. Treatments could be on ...

How has testosterone been historically misunderstood, and what implications does that have for current public policy?

While some research has shown benefits for patients who qualify, questions remain about the therapy's long-term risks and use among men without a medical need.

Pete Hegseth's Pentagon testosterone screening mandate has men asking whether their levels are normal. Here's what doctors say about diagnosis.

Defense Secretary Pete Hegseth announced that the U.S. military will begin annual screening for testosterone deficiency among service members ages 30 and older. Testosterone repla ...

On Wednesday, Defense Secretary Pete Hegseth made the startling announcement that the US military would begin requiring all ...

A balanced cortisol keeps you alert, and your BP and sugar steady. Trouble starts when it rises and stays high for too long.

Key Points Interested in Vertex Pharmaceuticals Incorporated? Here are five stocks we like better. Vertex Pharmaceuticals ...

Vertex Pharmaceuticals Incorporated’s $10B Crinetics Pharmaceuticals, Inc. buy adds PALSONIFY & a Phase 3 CAH asset. Click for more on VRTZX and CRNX stock.